Articles liés à Suicidal Behavior in Alcohol and Drug Abuse and Dependence

Suicidal Behavior in Alcohol and Drug Abuse and Dependence - Couverture rigide

 
9781608769193: Suicidal Behavior in Alcohol and Drug Abuse and Dependence

Synopsis

Suicidal behaviour is a major medical and social problem. Multiple lines of evidence suggest that alcohol and drug abuse is associated with suicidal ideation, attempts and suicides. Next to depression, alcoholism and drug abuse are the psychiatric conditions most strongly associated with suicide attempts and completed suicides. Alcohol and drugs are involved in about 50 percent of all suicide attempts. About 25 percent of completed suicides occur among individuals with alcoholism or drug abuse. Acute substance use makes suicide more likely. Nearly all alcoholic suicides occur among active drinkers, and alcohol consumption often immediately precedes the suicide. Individuals who drink a significant among of alcohol before a suicide attempt make more serious suicide attempts. Clinicians should be educated about a risk of suicidal behaviour among individuals with substance abuse. The book describes the current state of knowledge of this difficult and controversial issue. Clinical, epidemiological, neurobiological, cross-cultural, and treatment aspects are discussed. The results of the newest studies are presented. This book is mostly for M.D. or PH.D. level professionals but may be of significant interest to mental health counsellors, medical and psychology students, and lay people.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

À propos de l'auteur

Leo Sher, MD is a psychiatrist with a background in internal medicine. His areas of research and clinical expertise include neurobiology, diagnosis, and treatment of mood, anxiety, and personality disorders, alcoholism, and suicidal behavior. He is Associate Professor of Psychiatry at Icahn School of Medicine at Mount Sinai and Director of the Inpatient Psychiatry Service at the James J Peters VA Medical Center in New York. He has authored about 600 scientific publications, is a reviewer for numerous medical journals, the recipient of several awards and the first researcher in North America who introduced the use of the combined dexamethasone suppression/corticotropin-releasing hormone stimulation test for psychiatric purposes. Dr. Sher has experience as a forensic psychiatric expert and consultant.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.